A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants - Trial NCT06344728
Access comprehensive clinical trial information for NCT06344728 through Pure Global AI's free database. This Phase 1 trial is sponsored by Insmed Incorporated and is currently Recruiting. The study focuses on Healthy Participants. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Insmed Incorporated
Timeline & Enrollment
Phase 1
Apr 30, 2024
May 21, 2024
Primary Outcome
Relative Bioavailability Between Brensocatib Pediatric Oral Solution and Oral Tablets for Area Under the Concentration-time Curve from Time 0 Extrapolated to Infinity (AUC∞) of Brensocatib in Plasma
Summary
The primary purpose of this study is to determine the relative bioavailability of brensocatib
 between the pediatric oral solution and oral tablets in healthy participants.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06344728
Non-Device Trial